LBF20207PG70: Difference between revisions
New page: {{Lipid/Header}} {{Hierarchy|{{PAGENAME}}}} {{Metabolite |LipidBank=XPR1765 |LipidMaps=LMFA03010083 |SysName=&&(9beta,11alpha,15R) -Trihydroxy-16,16-dimethyl-prosta- (5-cis,13-trans) -di... |
(No difference)
|
Revision as of 10:51, 16 September 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1765 |
| LipidMaps | LMFA03010083 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207PG70 |
| 16,16-dimethyl Prostaglandin F2β | |
|---|---|
| |
| Structural Information | |
| &&(9β,11α,15R) -Trihydroxy-16,16-dimethyl-prosta- (5-cis,13-trans) -dien-1-oic acid | |
| |
| Formula | C22H38O5 |
| Exact Mass | 382.271924326 |
| Average Mass | 382.53412000000003 |
| SMILES | [C@@H]([C@@H]1C=C[C@@H](C(CCCC)(C)C)O)(C[C@@H](O)[C@@H]1CC=CCCCC(O)=O)O |
| Physicochemical Information | |
| 16,16-dimethyl Prostaglandin F2 beta reduce asthmatic bronchospasm. Allegra_L et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
